BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6841013)

  • 1. Reversal of galactose cataract with Sorbinil in rats.
    Hu TS; Datiles M; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1983 May; 24(5):640-4. PubMed ID: 6841013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevention and reversal of galactose cataract in rats with topical Sorbinil.
    Hu TS; Merola LO; Kuwabara T; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1984 May; 25(5):603-5. PubMed ID: 6715136
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galactose cataract prevention with sorbinil, an aldose reductase inhibitor: a light microscopic study.
    Datiles M; Fukui H; Kuwabara T; Kinoshita JH
    Invest Ophthalmol Vis Sci; 1982 Feb; 22(2):174-9. PubMed ID: 6799419
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aldose reductase inhibitors and prevention of galactose cataracts in rats.
    Unakar N; Tsui J; Johnson M
    Invest Ophthalmol Vis Sci; 1989 Jul; 30(7):1623-32. PubMed ID: 2545646
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reversal of stage-I sugar cataract by Sorbinil, an aldose reductase inhibitor.
    Beyer-Mears A; Cruz E; Varagiannis E
    Pharmacology; 1985; 31(2):88-96. PubMed ID: 3927328
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergism of sorbinil and normal diet on reversal of stage-II sugar cataract.
    Beyer-Mears A; Kelly K; Cruz E
    Pharmacology; 1985; 31(3):170-9. PubMed ID: 3931105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Prevention of rat galactose cataract with topical aldose reductase inhibitor, E-1008].
    Tasaka H; Akagi Y; Yoshikawa T; Ikebe H; Takahashi Y; Chamoto K; Miyamoto Y; Terubayashi H
    Nippon Ganka Gakkai Zasshi; 1987 Feb; 91(2):246-53. PubMed ID: 3111200
    [No Abstract]   [Full Text] [Related]  

  • 8. Dose-dependent prevention of sugar cataracts in galactose-fed dogs by the aldose reductase inhibitor M79175.
    Sato S; Mori K; Wyman M; Kador PF
    Exp Eye Res; 1998 Feb; 66(2):217-22. PubMed ID: 9533847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of sugar cataract in the dog.
    Sato S; Takahashi Y; Wyman M; Kador PF
    Invest Ophthalmol Vis Sci; 1991 May; 32(6):1925-31. PubMed ID: 1903366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sorbinil prevention of diabetic-like retinopathy in the galactose-fed rat model.
    Robison WG; Laver NM; Jacot JL; Glover JP
    Invest Ophthalmol Vis Sci; 1995 Nov; 36(12):2368-80. PubMed ID: 7591626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of sorbinil, an aldose reductase inhibitor, on the corneal endothelium in galactosemic dogs.
    Datiles MB; Kador PF; Kashima K; Kinoshita JH; Sinha A
    Invest Ophthalmol Vis Sci; 1990 Nov; 31(11):2201-4. PubMed ID: 2122961
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cataract formation through the polyol pathway is associated with free radical production.
    Kubo E; Miyoshi N; Fukuda M; Akagi Y
    Exp Eye Res; 1999 Apr; 68(4):457-64. PubMed ID: 10192803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of galactose-induced alterations in ocular lens with sorbinil.
    Unakar NJ; Tsui JY
    Exp Eye Res; 1983 May; 36(5):685-94. PubMed ID: 6303825
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultrastructural cytochemistry: effect of Sorbinil on arylsulfatases in cataractous lenses.
    Harries W; Tsui J; Unakar NJ
    Curr Eye Res; 1985 Jun; 4(6):657-66. PubMed ID: 4028788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of in utero galactose-induced cataract development by an aldose reductase inhibitor in rat--electron microscopic study.
    Teshima R; Taura T; Okamura R
    Jpn J Ophthalmol; 1993; 37(2):192-8. PubMed ID: 8230845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Galactose-induced retinal capillary basement membrane thickening: prevention by Sorbinil.
    Frank RN; Keirn RJ; Kennedy A; Frank KW
    Invest Ophthalmol Vis Sci; 1983 Nov; 24(11):1519-24. PubMed ID: 6642931
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of aldose reductase inhibitors on lenticular dulcitol level in galactose fed rats.
    Unakar NJ; Tsui JY; Johnson MJ
    J Ocul Pharmacol; 1992; 8(3):199-212. PubMed ID: 1453083
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aldose reductase inhibitors and galactose toxicity in neonatal and maternal rat lenses.
    Unakar NJ; Tsui J; Anthony P; Johnson M
    J Ocul Pharmacol; 1993; 9(4):341-53. PubMed ID: 8106840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acid phosphatase II. Cytochemical localization in lenses of normal and galactose-fed rats.
    Unakar NJ; Harries W; Tsui J
    Exp Eye Res; 1985 Jan; 40(1):117-26. PubMed ID: 3920063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased ocular blood flow and 125I-albumin permeation in galactose-fed rats: inhibition by sorbinil.
    Tilton RG; Chang K; Weigel C; Eades D; Sherman WR; Kilo C; Williamson JR
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):861-8. PubMed ID: 3372163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.